Vesalio
9
1
3
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
11.1%
1 terminated/withdrawn out of 9 trials
50.0%
-36.5% vs industry average
0%
0 trials in Phase 3/4
100%
1 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
NATURE (EnVast as an Adjunct PPCI in Subjects Presenting With STEMI)
Role: lead
NeVa ONE Registry Study
Role: lead
NeVa Retrospective Comparative SR Study
Role: lead
Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts
Role: lead
FIrst-Pass Reperfusion With the NeVa Stent-Retriever Trial
Role: lead
The Vesalio NeVa Stent Retriever Study for Treatment of Large Vessel Occlusion Strokes: CLEAR Study
Role: lead
The Vesalio NeVa Stent Retriever Study for Treatment of Large Vessel Occlusion Strokes
Role: lead
The Vesalio NeVa Stent Retriever Registry Study for Treatment of Large Vessel Occlusion Strokes
Role: lead
Vesalio NeVa VS for Symptomatic Cerebral Vasospasm Following aSAH (The VITAL Study)
Role: lead
All 9 trials loaded